Clinical Focus
Business Focus
Spotlight
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.
The National Institutes of Health has published an update to its guidance on seasonal influenza to address vaccination, testing, and treatment when the influenza and SARS-CoV-2 viruses are cocirculating.
This section of the guideline includes:
- Clinical presentation similarities/differences between the 2 viruses
- Potential for coinfection with influenza and SARS-CoV-2
- Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
- Treatment of influenza in the setting of cocirculatling SARS-CoV-2
Following is a topline summary of the guideline in a short slide show.
Related Videos
Related Content
Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen
October 31st 2023Article
Remdesivir use was associated with increased survival among patients hospitalized with COVID-19 requiring supplemental oxygen across SARS-CoV-2 variants of concern, report researchers.
